Global Biotherapeutics Cell Line Development Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Biotherapeutics Cell Line Development Revenue
• 1.4 Market by Type
  • 1.4.1 Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Transfection & Selection
  • 1.4.3 Single Cell Cloning
• 1.5 Market by Application
  • 1.5.1 Global Biotherapeutics Cell Line Development Market Share by Application: 2020 VS 2026
  • 1.5.2 In-house
  • 1.5.3 Outsource
  • 1.5.4 Hybrid
  • 1.5.5 Do-It-Yourself (DIY)
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Biotherapeutics Cell Line Development Market Perspective (2015-2026)
• 2.2 Global Biotherapeutics Cell Line Development Growth Trends by Regions
  • 2.2.1 Biotherapeutics Cell Line Development Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Biotherapeutics Cell Line Development Historic Market Share by Regions (2015-2020)
  • 2.2.3 Biotherapeutics Cell Line Development Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Biotherapeutics Cell Line Development Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Biotherapeutics Cell Line Development Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Biotherapeutics Cell Line Development Players by Market Size
  • 3.1.1 Global Top Biotherapeutics Cell Line Development Players by Revenue (2015-2020)
  • 3.1.2 Global Biotherapeutics Cell Line Development Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Biotherapeutics Cell Line Development Market Concentration Ratio
  • 3.2.1 Global Biotherapeutics Cell Line Development Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Biotherapeutics Cell Line Development Revenue in 2019
• 3.3 Biotherapeutics Cell Line Development Key Players Head office and Area Served
• 3.4 Key Players Biotherapeutics Cell Line Development Product Solution and Service
• 3.5 Date of Enter into Biotherapeutics Cell Line Development Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Biotherapeutics Cell Line Development Historic Market Size by Type (2015-2020)
• 4.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Biotherapeutics Cell Line Development Market Size by Application (2015-2020)
• 5.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Biotherapeutics Cell Line Development Market Size (2015-2020)
• 6.2 Biotherapeutics Cell Line Development Key Players in North America (2019-2020)
• 6.3 North America Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
• 6.4 North America Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Biotherapeutics Cell Line Development Market Size (2015-2020)
• 7.2 Biotherapeutics Cell Line Development Key Players in Europe (2019-2020)
• 7.3 Europe Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
• 7.4 Europe Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

8 China

• 8.1 China Biotherapeutics Cell Line Development Market Size (2015-2020)
• 8.2 Biotherapeutics Cell Line Development Key Players in China (2019-2020)
• 8.3 China Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
• 8.4 China Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Biotherapeutics Cell Line Development Market Size (2015-2020)
• 9.2 Biotherapeutics Cell Line Development Key Players in Japan (2019-2020)
• 9.3 Japan Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
• 9.4 Japan Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Biotherapeutics Cell Line Development Market Size (2015-2020)
• 10.2 Biotherapeutics Cell Line Development Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
• 10.4 Southeast Asia Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

11 India

• 11.1 India Biotherapeutics Cell Line Development Market Size (2015-2020)
• 11.2 Biotherapeutics Cell Line Development Key Players in India (2019-2020)
• 11.3 India Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
• 11.4 India Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Biotherapeutics Cell Line Development Market Size (2015-2020)
• 12.2 Biotherapeutics Cell Line Development Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
• 12.4 Central & South America Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Becton Dickinson & Company
  • 13.1.1 Becton Dickinson & Company Company Details
  • 13.1.2 Becton Dickinson & Company Business Overview
  • 13.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Introduction
  • 13.1.4 Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2015-2020))
  • 13.1.5 Becton Dickinson & Company Recent Development
• 13.2 Beckman Coulter
  • 13.2.1 Beckman Coulter Company Details
  • 13.2.2 Beckman Coulter Business Overview
  • 13.2.3 Beckman Coulter Biotherapeutics Cell Line Development Introduction
  • 13.2.4 Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 13.2.5 Beckman Coulter Recent Development
• 13.3 Boehringer Ingelheim Group
  • 13.3.1 Boehringer Ingelheim Group Company Details
  • 13.3.2 Boehringer Ingelheim Group Business Overview
  • 13.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Introduction
  • 13.3.4 Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 13.3.5 Boehringer Ingelheim Group Recent Development
• 13.4 Catalent Inc.
  • 13.4.1 Catalent Inc. Company Details
  • 13.4.2 Catalent Inc. Business Overview
  • 13.4.3 Catalent Inc. Biotherapeutics Cell Line Development Introduction
  • 13.4.4 Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 13.4.5 Catalent Inc. Recent Development
• 13.5 CMC Biologics A/S
  • 13.5.1 CMC Biologics A/S Company Details
  • 13.5.2 CMC Biologics A/S Business Overview
  • 13.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Introduction
  • 13.5.4 CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 13.5.5 CMC Biologics A/S Recent Development
• 13.6 Lonza Group Ltd.
  • 13.6.1 Lonza Group Ltd. Company Details
  • 13.6.2 Lonza Group Ltd. Business Overview
  • 13.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Introduction
  • 13.6.4 Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 13.6.5 Lonza Group Ltd. Recent Development
• 13.7 EMD Millipore
  • 13.7.1 EMD Millipore Company Details
  • 13.7.2 EMD Millipore Business Overview
  • 13.7.3 EMD Millipore Biotherapeutics Cell Line Development Introduction
  • 13.7.4 EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 13.7.5 EMD Millipore Recent Development
• 13.8 Partec (Sysmex Corporation)
  • 13.8.1 Partec (Sysmex Corporation) Company Details
  • 13.8.2 Partec (Sysmex Corporation) Business Overview
  • 13.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Introduction
  • 13.8.4 Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 13.8.5 Partec (Sysmex Corporation) Recent Development
• 13.9 ProBioGen AG
  • 13.9.1 ProBioGen AG Company Details
  • 13.9.2 ProBioGen AG Business Overview
  • 13.9.3 ProBioGen AG Biotherapeutics Cell Line Development Introduction
  • 13.9.4 ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 13.9.5 ProBioGen AG Recent Development
• 13.10 Selexis SA
  • 13.10.1 Selexis SA Company Details
  • 13.10.2 Selexis SA Business Overview
  • 13.10.3 Selexis SA Biotherapeutics Cell Line Development Introduction
  • 13.10.4 Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 13.10.5 Selexis SA Recent Development
• 13.11 Sigma-Aldrich Co. LLC.
  • 10.11.1 Sigma-Aldrich Co. LLC. Company Details
  • 10.11.2 Sigma-Aldrich Co. LLC. Business Overview
  • 10.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Introduction
  • 10.11.4 Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 10.11.5 Sigma-Aldrich Co. LLC. Recent Development
• 13.12 Sony Biotechnology Inc.
  • 10.12.1 Sony Biotechnology Inc. Company Details
  • 10.12.2 Sony Biotechnology Inc. Business Overview
  • 10.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Introduction
  • 10.12.4 Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 10.12.5 Sony Biotechnology Inc. Recent Development
• 13.13 Thermo Fisher Scientific Inc.
  • 10.13.1 Thermo Fisher Scientific Inc. Company Details
  • 10.13.2 Thermo Fisher Scientific Inc. Business Overview
  • 10.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Introduction
  • 10.13.4 Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
  • 10.13.5 Thermo Fisher Scientific Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer